TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

EXOLIN

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: US

Quick snapshot

EXOLIN

ST13

US500000079216396

Class

5, 10, 42

Filing

79216396

Registration

5477924

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

02/20/2026

Classification

Registered

Trademark type

Word

Nice classes

5, 10, 42

Filing date

06/08/2017

Registration date

05/29/2018

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/13/2024

Last transaction

02/20/2026

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

4

Owner type

34

Owner location

FR

Examiner

BEVERLY, JOSETTE MICHELLE

Law office

M60

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

DEFYMED

Representatives

ANDREW W. CHU

Technical classification

Nice Classes

Class 5Class 10Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Cultures of microorganisms for medical or veterinary use; biological tissue cultures for medical or veterinary use; enzymes for medical or veterinary use; vascular grafts of living tissues; hormones for medical use; surgical implants composed of living tissue; medicines for intestinal disorders in humans; biological preparations for medical or veterinary use in treating metabolic disorders; chemical-pharmaceutical preparations for the treatment of diabetes; chemical preparations for medical or veterinary use for the treatment of diabetes; chemical preparations for pharmaceutical use in the treatment of diabetes; preparations of microorganisms for medical and veterinary use in the treatment of diabetes; diagnostic preparations for medical or veterinary use

Class 10

Surgical and medical apparatus and instruments for use in implanting insulin injectors; catheters; implantable devices for the subcutaneous release of medicated substances sold empty; surgical implants comprised of artificial materials; vacuum pumps for medical use; injector devices for medical use in delivering pharmaceuticals

Class 42

Conducting clinical trials for others in the fields of medical devices and pharmaceuticals; research and development of new products for others; research and development in the field of bioartificial medical devices; research and development in the field of microorganisms and cells; research and development in the field of therapeutics; biological research services; bacteriological research services; chemical research; scientific research; technical research in the field of pharmaceutical studies; services provided by consultants relating to scientific research and development in the field of therapeutics; scientific laboratory services

Publications

History of USPTO decisions and trademark events.

29 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

02/19/2026

INTS

TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB

02/01/2026

INPC

INVALIDATION PROCESSED

02/01/2026

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

08/13/2025

C71T

CANCELLED SECTION 71

12/13/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

05/29/2023

ADCH

CHANGE OF NAME/ADDRESS REC'D FROM IB

12/11/2021

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

09/29/2018

FICS

FINAL DISPOSITION NOTICE SENT TO IB

09/11/2018

FIMP

FINAL DISPOSITION PROCESSED

09/11/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

08/29/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

05/29/2018

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/13/2018

PUBO

PUBLISHED FOR OPPOSITION

03/13/2018

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/21/2018

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/03/2018

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

01/25/2018

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

01/25/2018

ALIE

ASSIGNED TO LIE

01/25/2018

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

01/11/2018

RFNT

REFUSAL PROCESSED BY IB

10/14/2017

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

09/22/2017

RFRR

REFUSAL PROCESSED BY MPU

09/22/2017

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/22/2017

CNRT

NON-FINAL ACTION WRITTEN

09/21/2017

MAFR

APPLICATION FILING RECEIPT MAILED

09/19/2017

DOCK

ASSIGNED TO EXAMINER

09/15/2017

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/15/2017

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

09/14/2017

Continuous trademark protection

Get notified about every new filing that threatens EXOLIN or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.